Response to paclitaxel in adenoid cystic carcinoma of the salivary glands

Head and Neck

Volumn 30, Issue 6, 2008, Pages 810-814

  Till, Brian G ^a,b   Martins, Renato G ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ACC; Adenoid cystic carcinoma; Chemotherapy; Paclitaxel; Salivary gland

Indexed keywords

CARBOPLATIN; CASTOR OIL; CISPLATIN; DOXORUBICIN; LEVOTHYROXINE; LIOTHYRONINE; LUGOL; NAVELBINE; NICOTINIC ACID; PACLITAXEL; PANCREATIN; POTASSIUM;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; JAW TUMOR; LUNG METASTASIS; MALE; MAXILLA RESECTION; METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHIC PAIN; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, ADENOID CYSTIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; SALIVARY GLAND NEOPLASMS;

EID: 46249120429     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20731     Document Type: Article

References (9)

1. Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004;12:127-132.
2. Gilbert J, Li Y, Pinto HA, et al. Phase II trial of Taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Head Neck 2006;28: 197-204.
3. Gurney TA, Eisele DW, Weinberg V, Shin E, Lee N. Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope 2005;115: 1278-1282.
4. Huang M, Ma D, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 1997;26: 435-439.
5. Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673-2678.
6. Nakashima D, Uzawa K, Kasamatsu A, et al. Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands. Int J Cancer 2006;118:704-713.
7. Airoldi M, Fornari G, Pedani F, et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anti-cancer Res 2000;20:3781-3783.
8. Haddad RI, Posner MR, Busse PM, et al. Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach. Am J Clin Oncol 2006;29: 153-157.
9. Maruya S, Namba A, Matsubara A, et al. Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel. Int J Clin Oncol 2006; 11:403-406.